Company / Free Cash Flow per Share
MBX Biosciences, Inc. Free Cash Flow per Share History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$5.22
FY2024
5-year range
-$31.52 / -$5.22
FY2023-FY2024
Trend
+83.4%
vs FY2023
Sector context
#179 of 192
Health Care
What the data says
Among 192 Health Care companies, MBX Biosciences, Inc. is in the bottom 7% for free cash flow per share.
Based on SEC 10-K filings.
-5.22 in FY2024.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 192This company -$5.22 Sector average -$19.84
▼
+73.7% above sector average
Key checks
Key Insights
- In FY2024, free cash flow per share increased 83.4% year-over-year.
- Ranks #179 out of 192 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 9.64 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$5.22 | +83.4% |
| FY2023 | -$31.52 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026